麻豆淫院

Zebrafish have the remarkable and rare ability to regrow and repair their hearts after damage. New research from Caltech and UC Berkeley has identified the circuit of genes controlling this ability and offers clues about how a human heart might someday be repaired after damage, such as a heart attack or in cases of congenital heart defects.

The research was a collaboration between the laboratories of Marianne Bronner, Caltech's Edward B. Lewis Professor of Biology and director of the Beckman Institute, and developmental biologist Megan Martik of UC Berkeley. A paper describing the study was in the Proceedings of the National Academy of Sciences.

The heart is made up of many different kinds of cells, such as muscle, nerve, and blood vessel cells. In zebrafish, around 12% to 15% of these cells originate from a specific population of stem cells called neural crest cells.

The Bronner and Martik laboratories have studied neural crest cells and their crucial role in development in many lab animal models, including zebrafish and lamprey. Humans also have analogous neural crest cells that give rise to varied cell types in almost every organ of the body, ranging from cells of the facial skeleton to cells of the nervous system.

In the new study, the team found that the heart cells derived from neural crest cells are responsible for orchestrating the reconstruction process in damaged zebrafish hearts. When those neural crest鈥揹erived heart cells were removed in experiments, the hearts lost their ability to regenerate after damage.

Importantly, the study identified the complex circuit of genes that is activated during regeneration. These genes, the researchers found, are crucial for normal embryonic development and then are inactivated during the animal's adult life鈥攂ut are reactivated to enable tissue regeneration.

Next, the team aims to study how these cells reactivate such gene programs to answer the question: What signal triggers the activation of these genes after damage? Ultimately, the work could reveal whether humans could activate analogous genes if given that same signal.

The Martik team is currently using CRISPR technology鈥攁 common gene-editing technique鈥攐n human heart cells in lab dishes to determine if these genes can be reactivated.